BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16758574)

  • 1. Stiffness and contractile properties of avian normal and dystrophic muscle bundles as measured by sinusoidal length perturbations.
    Feit H; Kawai M; Schulman MI
    Muscle Nerve; 1985; 8(6):503-10. PubMed ID: 16758574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of collagen crosslinking in the increased stiffness of avian dystrophic muscle.
    Feit H; Kawai M; Mostafapour AS
    Muscle Nerve; 1989 Jun; 12(6):486-92. PubMed ID: 2725576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contractile properties of skinned muscle fibres from young and adult normal and dystrophic (mdx) mice.
    Williams DA; Head SI; Lynch GS; Stephenson DG
    J Physiol; 1993 Jan; 460():51-67. PubMed ID: 8487206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Ca2+- and Sr2+-activated tension in functionally skinned chicken fibers of normal and dystrophic skeletal and normal cardiac muscle.
    Kerrick WG; Hoar PE; Malencik DA; Stamps L; Fischer EH
    Pflugers Arch; 1979 Jul; 381(1):53-62. PubMed ID: 573454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Energetics of isometric contraction in dystrophic fast and slow muscles.
    Nwoye LO; Goldspink G
    Muscle Nerve; 1982 Jan; 5(1):69-72. PubMed ID: 7057809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of enzymatically isolated skeletal fibres from mice with muscular dystrophy.
    Head SI; Stephenson DG; Williams DA
    J Physiol; 1990 Mar; 422():351-67. PubMed ID: 2352184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in isometric contractile properties of fast-twitch and slow-twitch skeletal muscle of C57BL/6J dy2J/dy2J dystrophic mice during postnatal development.
    Bressler BH; Jasch LG; Ovalle WK; Slonecker CE
    Exp Neurol; 1983 May; 80(2):457-70. PubMed ID: 6840250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low frequency chronic electrical stimulation of normal and dystrophic chicken muscle.
    Barnard EA; Barnard PJ; Jarvis JC; Lai J
    J Physiol; 1986 Jul; 376():377-409. PubMed ID: 3795078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urocortins improve dystrophic skeletal muscle structure and function through both PKA- and Epac-dependent pathways.
    Reutenauer-Patte J; Boittin FX; Patthey-Vuadens O; Ruegg UT; Dorchies OM
    Am J Pathol; 2012 Feb; 180(2):749-62. PubMed ID: 22192627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium and strontium activation of single skinned muscle fibres of normal and dystrophic mice.
    Fink RH; Stephenson DG; Williams DA
    J Physiol; 1986 Apr; 373():513-25. PubMed ID: 3746681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term clenbuterol administration alters the isometric contractile properties of skeletal muscle from normal and dystrophin-deficient mdx mice.
    Hayes A; Williams DA
    Clin Exp Pharmacol Physiol; 1994 Oct; 21(10):757-65. PubMed ID: 7867226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myosin expression in hypertrophied fast twitch and slow tonic muscles of normal and dystrophic chickens.
    Kennedy JM; Zak R; Gao L
    Muscle Nerve; 1991 Feb; 14(2):166-77. PubMed ID: 1825696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contractile function and low-intensity exercise effects of old dystrophic (mdx) mice.
    Hayes A; Williams DA
    Am J Physiol; 1998 Apr; 274(4):C1138-44. PubMed ID: 9575811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased resistance of the collagen in avian dystrophic muscle to collagenolytic attack: evidence for increased crosslinking.
    Feit H; Kawai M; Mostafapour AS
    Muscle Nerve; 1989 Jun; 12(6):476-85. PubMed ID: 2542788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
    Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
    J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining potential drug therapies for muscular dystrophy utilising the dy/dy mouse: I. Clenbuterol.
    Hayes A; Williams DA
    J Neurol Sci; 1998 May; 157(2):122-8. PubMed ID: 9619633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of force and stiffness in normal and dystrophic mouse muscles.
    Gordon T; Stein RB
    Muscle Nerve; 1988 Aug; 11(8):819-27. PubMed ID: 3173407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Force and stiffness of old dystrophic (mdx) mouse skeletal muscles.
    Bobet J; Mooney RF; Gordon T
    Muscle Nerve; 1998 Apr; 21(4):536-9. PubMed ID: 9533791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of graded duration of stretch on normal and dystrophic skeletal muscle.
    Frankeny JR; Holly RG; Ashmore CR
    Muscle Nerve; 1983 May; 6(4):269-77. PubMed ID: 6866007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice.
    Schertzer JD; Ryall JG; Lynch GS
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E499-505. PubMed ID: 16621899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.